$ Value
$0
Shares
3,176,245
Price
$0
Filed
Jun 27
Insider
Name
QVT Financial LP
Title
—
CIK
0001290162
Roles
Transaction Details
Transaction Date
2025-06-25
Code
J
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
19,347,727
Footnotes
On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd. contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares. | Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 29,381,635 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT P&E, QVT DCH and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT. | QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Shares held by, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. | QVT is the investment manager of QVT Roiv, shares voting and investment control over the Shares held directly by QVT Roiv and therefore may be deemed to beneficially own such Shares. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
Filing Info
QVT Financial LP's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-25 | ROIV | J | $0 |
| 2025-06-25 | ROIV | J | $0 |
| 2025-06-25 | ROIV | J | $0 |
| 2025-06-25 | ROIV | J | $0 |
| 2025-06-25 | ROIV | J | $0 |
| 2025-06-25 | ROIV | J | $0 |
Other Insiders at ROIV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOMTAZEE JAMES C | — | — | 2026-04-17 |
| Fitzgerald Meghan | — | $1.9M | 2026-03-26 |
| Oren Ilan | — | — | 2026-04-17 |
|
Torti Frank
President and Vant Chair
|
— | — | 2026-03-31 |
|
Sukhatme Mayukh
President & CIO
|
— | — | 2026-03-31 |
|
Gline Matthew
CEO
|
— | $8.4M | 2026-04-16 |
|
Venker Eric
President & Immunovant CEO
|
— | $5.9M | 2026-04-20 |
| Epperly Melissa B, | — | — | 2026-04-17 |
|
Pulik Richard
CFO
|
— | — | 2026-04-20 |
|
Humes Jennifer
Chief Accounting Officer
|
— | $384K | 2026-04-20 |